Bempedoic Acid has a new mechanism of action compared to existing products. It is administered as a 180-mg dose, is approved by the US FDA and European Union for the treatment of hypercholesterolemia.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/BJ7xzbA
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Sun Pharma to launch Brillo, a first-in-class oral lipid-lowering drug in India
https://ift.tt/7beW3w9
No comments:
Post a Comment